FormulationX To Debut At INTERPHEX 2018; Elsevier A Foundation Sponsor

NEW YORK, NY - Sep 5, 2017 - International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today announced FormulationX will debut at INTERPHEX 2018 featuring exhibits, technical conference and networking focused on drug substance. Elsevier, a leading information analytics company specializing in science and health, will serve as a Foundation Sponsor of FormulationX.  Elsevier is a long-established organization that is widely recognized as a key resource in helping progress science, advance healthcare and improve performance. The collaboration aligns with the goals of both organizations to offer first-hand access to the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. INTERPHEX will take place April 17-19, 2018 at the Javits Center, New York, NY.

"FormulationX was designed to meet the needs of the North American market and drug substance industry professionals," explained Melissa Ashley, Senior Vice President, INTERPHEX. “Pharmaceutical and biotechnology companies’ around the world expect an increase in spend for raw materials, excipients, intermediates, fine chemicals and API in the coming years due to the increasing demand for new drugs, innovation in excipients and new technologies used in manufacturing.”

Ashley continued, “Increasing the presence of drug substance suppliers catering to the needs of targeted attendee groups will further strengthen the value proposition of INTERPHEX offering an even more robust platform of formulation through commercialization technologies, products and services. With the debut of FormulationX, INTERPHEX is well-positioned to continue its leadership role in delivering value to our customers and access to a full-range of technologies and industry expertise to address challenges faced by the industries we serve."

“Our Foundation Sponsor designation in support of INTERPHEX underscores our commitment to help the research community make discoveries, collaborate with industry colleagues and share insight, expanding the boundaries of knowledge and intelligence for the benefit of humanity,” said Tim Hoctor, Vice President of Professional Services, Elsevier. “We believe personalized technology is helping researchers accelerate their research and make unanticipated connections, which is particularly important as the body of knowledge and data continues to grow rapidly. INTERPHEX provides the ideal platform to for these connections to happen via a strong technical learning program.”

Located within INTERPHEX 2018, FormulationX offers an opportunity to meet, network and share expertise in a dedicated space featuring exhibitors and a no cost technical conference program specific to drug substance. Companies interested in exhibiting at the first annual FormulationX should visit www.formulation-x.com to view available space selections and contact Mike Putnam at mputnam@reedexpo.com or 203.840.5596.

Registration for INTERPHEX and FormulationX is now open.